{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:07:39Z","timestamp":1790942859288,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1124\/jpet.107.127415","type":"journal-article","created":{"date-parts":[[2007,9,7]],"date-time":"2007-09-07T00:48:38Z","timestamp":1189126118000},"page":"838-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":210,"title":["Anxiolytic-Like Effects of \u03ba-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats"],"prefix":"10.1016","volume":"323","author":[{"given":"Allison T.","family":"Knoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward G.","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Ivy","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Carlezon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.127415_bib1","unstructured":"Artaiz I, Zazpe A, and Del Rio J (1998) Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice. Behav Pharmacol 9: 103\u2013112."},{"key":"10.1124\/jpet.107.127415_bib2","doi-asserted-by":"crossref","unstructured":"Bagdy G, Graf M, Anheuer ZE, Modos EA, and Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4: 399\u2013408.","DOI":"10.1017\/S1461145701002632"},{"key":"10.1124\/jpet.107.127415_bib3","doi-asserted-by":"crossref","unstructured":"Bals-Kubik R, Ableitner A, Herz A, and Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264: 489\u2013495.","DOI":"10.1016\/S0022-3565(25)10296-6"},{"key":"10.1124\/jpet.107.127415_bib4","doi-asserted-by":"crossref","unstructured":"Beardsley PM, Howard JL, Shelton KL, and Carroll FI (2005) Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) 183: 118\u2013126.","DOI":"10.1007\/s00213-005-0167-4"},{"key":"10.1124\/jpet.107.127415_bib5","doi-asserted-by":"crossref","unstructured":"Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, and LeDoux JE (2004) The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55: 1171\u20131178.","DOI":"10.1016\/j.biopsych.2004.02.029"},{"key":"10.1124\/jpet.107.127415_bib6","doi-asserted-by":"crossref","unstructured":"Carlezon WA Jr, Beguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, and Cohen BM (2006) Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316: 440\u2013447.","DOI":"10.1124\/jpet.105.092304"},{"key":"10.1124\/jpet.107.127415_bib7","doi-asserted-by":"crossref","unstructured":"Carlezon WA Jr, Duman RS, and Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28: 436\u2013445.","DOI":"10.1016\/j.tins.2005.06.005"},{"key":"10.1124\/jpet.107.127415_bib8","doi-asserted-by":"crossref","unstructured":"Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, and Nestler EJ (1998) Regulation of cocaine reward by CREB. Science 282: 2272\u20132275.","DOI":"10.1126\/science.282.5397.2272"},{"key":"10.1124\/jpet.107.127415_bib9","doi-asserted-by":"crossref","unstructured":"Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, and Harris LS (2004) Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501: 111\u2013119.","DOI":"10.1016\/j.ejphar.2004.08.028"},{"key":"10.1124\/jpet.107.127415_bib10","doi-asserted-by":"crossref","unstructured":"Catalano G, Hakala SM, and Catalano MC (2000) Sertraline-induced panic attacks. Clin Neuropharmacol 23: 164\u2013168.","DOI":"10.1097\/00002826-200005000-00007"},{"key":"10.1124\/jpet.107.127415_bib11","doi-asserted-by":"crossref","unstructured":"Chavkin C, James IF, and Goldstein A (1982) Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215: 413\u2013415.","DOI":"10.1126\/science.6120570"},{"key":"10.1124\/jpet.107.127415_bib12","doi-asserted-by":"crossref","unstructured":"Drapier D, Bentue-Ferrer D, Laviolle B, Millet B, Allain H, Bourin M, and Reymann JM (2007) Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 176: 202\u2013209.","DOI":"10.1016\/j.bbr.2006.10.002"},{"key":"10.1124\/jpet.107.127415_bib13","unstructured":"Endoh T, Matsuura H, Tanaka C, and Nagase H (1992) Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 316: 30\u201342."},{"key":"10.1124\/jpet.107.127415_bib14","doi-asserted-by":"crossref","unstructured":"Fallon JH and Leslie FM (1986) Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249: 293\u2013336.","DOI":"10.1002\/cne.902490302"},{"key":"10.1124\/jpet.107.127415_bib15","doi-asserted-by":"crossref","unstructured":"File SE, Ouagazzal AM, Gonzalez LE, and Overstreet DH (1999) Chronic fluoxetine in tests of anxiety in rat lines selectively bred for differential 5-HT1A receptor function. Pharmacol Biochem Behav 62: 695\u2013701.","DOI":"10.1016\/S0091-3057(98)00208-1"},{"key":"10.1124\/jpet.107.127415_bib16","doi-asserted-by":"crossref","unstructured":"Griebel G, Moreau JL, Jenck F, Misslin R, and Martin JR (1994) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berl) 113: 463\u2013470.","DOI":"10.1007\/BF02245224"},{"key":"10.1124\/jpet.107.127415_bib17","doi-asserted-by":"crossref","unstructured":"Grillon C, Levenson J, and Pine DS (2007) A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology 32: 225\u2013231.","DOI":"10.1038\/sj.npp.1301204"},{"key":"10.1124\/jpet.107.127415_bib18","doi-asserted-by":"crossref","unstructured":"Heim C and Nemeroff CB (1999) The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol Psychiatry 46: 1509\u20131522.","DOI":"10.1016\/S0006-3223(99)00224-3"},{"key":"10.1124\/jpet.107.127415_bib19","unstructured":"Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC."},{"key":"10.1124\/jpet.107.127415_bib20","doi-asserted-by":"crossref","unstructured":"Jamot L, Matthes HW, Simonin F, Kieffer BL, and Roder JC (2003) Differential involvement of the mu and kappa opioid receptors in spatial learning. Genes Brain Behav 2: 80\u201392.","DOI":"10.1034\/j.1601-183X.2003.00013.x"},{"key":"10.1124\/jpet.107.127415_bib21","doi-asserted-by":"crossref","unstructured":"Jones DN and Holtzman SG (1992) Long term kappa-opioid receptor blockade following nor-binaltorphimine. Eur J Pharmacol 215: 345\u2013348.","DOI":"10.1016\/0014-2999(92)90055-9"},{"key":"10.1124\/jpet.107.127415_bib22","doi-asserted-by":"crossref","unstructured":"Kaufman J and Charney D (2000) Comorbidity of mood and anxiety disorders. Depress Anxiety 12 (Suppl 1): 69\u201376.","DOI":"10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K"},{"key":"10.1124\/jpet.107.127415_bib23","doi-asserted-by":"crossref","unstructured":"Kessler RC (1997) The effects of stressful life events on depression. Annu Rev Psychol 48: 191\u2013214.","DOI":"10.1146\/annurev.psych.48.1.191"},{"key":"10.1124\/jpet.107.127415_bib24","doi-asserted-by":"crossref","unstructured":"Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, and Carlezon WA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305: 323\u2013330.","DOI":"10.1124\/jpet.102.046433"},{"key":"10.1124\/jpet.107.127415_bib25","doi-asserted-by":"crossref","unstructured":"Mansour A, Fox CA, Akil H, and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22\u201329.","DOI":"10.1016\/0166-2236(95)93946-U"},{"key":"10.1124\/jpet.107.127415_bib26","doi-asserted-by":"crossref","unstructured":"McLaughlin JP, Marton-Popovici M, and Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23: 5674\u20135683.","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003"},{"key":"10.1124\/jpet.107.127415_bib27","doi-asserted-by":"crossref","unstructured":"Meloni EG, Gerety LP, Knoll AT, Cohen BM, and Carlezon WA Jr (2006) Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci 26: 3855\u20133863.","DOI":"10.1523\/JNEUROSCI.4957-05.2006"},{"key":"10.1124\/jpet.107.127415_bib28","doi-asserted-by":"crossref","unstructured":"Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, and Kapur S (2007) Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry 164: 630\u2013637.","DOI":"10.1176\/ajp.2007.164.4.630"},{"key":"10.1124\/jpet.107.127415_bib29","doi-asserted-by":"crossref","unstructured":"Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, Nanjo K, Matsuzawa K, Yamazaki M, and Suzuki T (2006) Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31: 739\u2013750.","DOI":"10.1038\/sj.npp.1300858"},{"key":"10.1124\/jpet.107.127415_bib30","doi-asserted-by":"crossref","unstructured":"Nestler EJ and Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151\u20131159.","DOI":"10.1016\/j.biopsych.2005.09.018"},{"key":"10.1124\/jpet.107.127415_bib31","doi-asserted-by":"crossref","unstructured":"Pellow S and File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24: 525\u2013529.","DOI":"10.1016\/0091-3057(86)90552-6"},{"key":"10.1124\/jpet.107.127415_bib32","doi-asserted-by":"crossref","unstructured":"Pfeiffer A, Brantl V, Herz A, and Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233: 774\u2013776.","DOI":"10.1126\/science.3016896"},{"key":"10.1124\/jpet.107.127415_bib33","doi-asserted-by":"crossref","unstructured":"Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, and Carlezon WA Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21: 7397\u20137403.","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001"},{"key":"10.1124\/jpet.107.127415_bib34","doi-asserted-by":"crossref","unstructured":"Prut L and Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3\u201333.","DOI":"10.1016\/S0014-2999(03)01272-X"},{"key":"10.1124\/jpet.107.127415_bib35","doi-asserted-by":"crossref","unstructured":"Ribeiro SC, Kennedy SE, Smith YR, Stohler CS, and Zubieta JK (2005) Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog Neuropsychopharmacol Biol Psychiatry 29: 1264\u20131280.","DOI":"10.1016\/j.pnpbp.2005.08.011"},{"key":"10.1124\/jpet.107.127415_bib36","doi-asserted-by":"crossref","unstructured":"Sandin J, Nylander I, Georgieva J, Schott PA, Ogren SO, and Terenius L (1998) Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect. Neuroscience 85: 375\u2013382.","DOI":"10.1016\/S0306-4522(97)00605-2"},{"key":"10.1124\/jpet.107.127415_bib37","doi-asserted-by":"crossref","unstructured":"Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, and Duman RS (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90: 1258\u20131268.","DOI":"10.1111\/j.1471-4159.2004.02589.x"},{"key":"10.1124\/jpet.107.127415_bib38","doi-asserted-by":"crossref","unstructured":"Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A, Le Meur M, Roques BP, Maldonado R, and Kieffer BL (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal. EMBO J 17: 886\u2013897.","DOI":"10.1093\/emboj\/17.4.886"},{"key":"10.1124\/jpet.107.127415_bib39","doi-asserted-by":"crossref","unstructured":"Thomas JB, Fix SE, Rothman RB, Mascarella SW, Dersch CM, Cantrell BE, Zimmerman DM, and Carroll FI (2004) Importance of phenolic address groups in opioid kappa receptor selective antagonists. J Med Chem 47: 1070\u20131073.","DOI":"10.1021\/jm030467v"},{"key":"10.1124\/jpet.107.127415_bib40","doi-asserted-by":"crossref","unstructured":"Todtenkopf MS, Marcus JF, Portoghese PS, and Carlezon WA Jr (2004) Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl) 172: 463\u2013470.","DOI":"10.1007\/s00213-003-1680-y"},{"key":"10.1124\/jpet.107.127415_bib41","doi-asserted-by":"crossref","unstructured":"Weiss IC, Pryce CR, Jongen-Relo AL, Nanz-Bahr NI, and Feldon J (2004) Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat. Behav Brain Res 152: 279\u2013295.","DOI":"10.1016\/j.bbr.2003.10.015"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524341795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.127415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:27:36Z","timestamp":1740004056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524341795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0022356524341795"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.127415","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiolytic-Like Effects of \u03ba-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.127415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}